Monoclonal antibody ICR12-CPG2 conjugate
Alternative Names: ICR12-CPG2; Monoclonal antibody ICR12-carboxypeptidase G2 conjugateLatest Information Update: 12 Aug 1998
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 12 Aug 1998 No-Development-Reported for Breast cancer in England (Unknown route)
- 09 Jul 1996 Preclinical development for Breast cancer in England (Unknown route)